New Study Advances Cancer Precision Therapies by Identifying Patients Who Benefit from Bexmarilimab treatment
Researchers have identified the conditions under which the antibody-drug bexmarilimab can activate the body's own defense system against cancer. TURKU, FINLAND, May 20, 2025 /EINPresswire.com/ -- Researchers at the University of Turku, Finland, have …